Stragen Pharma, part of the Stragen Group's companies, is a private Swiss pharmaceutical company, which for the last 20 years has focused on strategic generic products.

In-house R&D and regulatory expertise has enabled us to develop a full range of injectable, oral and topical products, with a particular focus on antibiotic, hormone and oncology markets. Stragen Pharma owns a large portfolio of Marketing Authorisations and distributes its products worldwide, either directly or through licensing agreements with the leaders in the generic industry.

Stragen Pharma’s concept is to offer a complete service to its customers, from proprietary development right through to delivery of the finished product at their warehouse and to focus on the timely development of strategic generics.